Healthcare & Life Sciences

MorphImmune

MorphImmune is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.

series-a
series-a
Stage
1
Investors

About MorphImmune

Based in the United States, MorphImmune is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

MorphImmune develops novel cancer immunotherapies by targeting tumor-specific peptides presented on cancer cells to enhance immune system recognition and destruction of tumors.

Explore MorphImmune's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States